We are building a deep and expanding pipeline of innovative products with near-term value creation opportunities across a broad spectrum of clinical conditions, without limiting ourselves to a particular medical specialty or call point. PAVmed’s current pipeline consists of six lead products with a collective annual market opportunity of more than $4 billion, focused on medical infusion, hand surgery, pediatric ear infections, and tissue ablation.
We choose projects to develop and commercialize based on a variety of characteristics which contribute to a strong commercial opportunity. We place a heavy emphasis on single-use, interventional medical device products with the potential for high margins and high impact in attractive markets, and, most importantly, streamlined pathways to initial regulatory clearance.
To expand our multi-product pipeline, we continue to explore promising ideas and opportunities that fulfill our project selection criteria, sourced internally and from innovative clinicians and academic medical centers. Our pipeline is dynamic, and we make adjustments to our development and commercialization based on real-time progress, changes in market conditions, commercial opportunities, and availability of resources.